Merit Financial Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3M Buy
4,808
+498
+12% +$292K 0.02% 626
2026
Q2
$2.28M Sell
4,310
-1,305
-23% -$602K 0.01% 697
2026
Q1
$2.7M Sell
5,615
-2,144
-28% -$1.1M 0.02% 563
2025
Q4
$4.36M Buy
7,759
+3,579
+86% +$2.03M 0.04% 390
2025
Q3
$2.15M Buy
4,180
+2,177
+109% +$950K 0.02% 555
2025
Q2
$629K Sell
2,003
-286
-12% -$85.9K 0.01% 990
2025
Q1
$697K Buy
2,289
+462
+25% +$155K 0.01% 800
2024
Q4
$607K Buy
+1,827
New +$620K 0.01% 655
2024
Q3
– Sell
-518
Closed -$213K – 911
2024
Q2
$213K Buy
+518
New +$205K ﹤0.01% 852

Other funds holding MEDP

Merit Financial Group's MEDP Position: Q3 2026 in Review

Merit Financial Group increased its Medpace (MEDP) stake by 12% in Q3 2026, buying an estimated $292K and bringing the position to 4,808 shares worth $3M. The position accounts for 0.02% of the portfolio, ranked #626.

Merit Financial Group first reported a position in MEDP in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.36M in Q4 2025. 762 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Merit Financial Group held 4,808 shares of Medpace worth $3M as of Q3 2026.
  • Merit Financial Group bought 498 Medpace shares in Q3 2026, an estimated $292K.
  • Medpace made up 0.02% of Merit Financial Group's portfolio in Q3 2026, its #626 holding.
  • Merit Financial Group first reported a position in Medpace in Q2 2024 and has held it in 9 quarters since.
  • Merit Financial Group's Medpace position peaked at $4.36M in Q4 2025.
  • 762 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Merit Financial Group's 13F filing for Q3 2026, filed 6 Nov 2026.